Cerebellar c9RAN proteins associate with clinical and neuropathological characteristics of C9ORF72 repeat expansion carriers

Autor: John A. Lucas, Keith A. Josephs, Clotilde Lagier-Tourenne, Jie Jiang, Tania F. Gendron, Amelia Robertson, Neill R. Graff-Radford, Monica Castanedes-Casey, Colleen S. Thomas, Marka van Blitterswijk, Beth K. Rush, Pamela Desaro, Joseph E. Parisi, Kevin B. Boylan, Julia E. Crook, David S. Knopman, Karen Overstreet, Dennis W. Dickson, Linda Rousseau, Ronald C. Petersen, Lillian M. Daughrity, Kevin F. Bieniek, Melissa E. Murray, Don W. Cleveland, Leonard Petrucelli, Rosa Rademakers, Bradley F. Boeve, Otto Pedraza, Dieter Edbauer
Jazyk: angličtina
Rok vydání: 2015
Předmět:
Male
Pathology
Cerebellum
complications [Motor Neuron Disease]
Messenger
Hippocampus
Dipeptide repeat proteins
metabolism [Hippocampus]
genetics [Cognition Disorders]
pathology [Frontal Lobe]
Cohort Studies
Cognition
C9orf72
complications [Frontotemporal Dementia]
80 and over
pathology [Cerebellum]
Amyotrophic lateral sclerosis
genetics [Frontotemporal Dementia]
Aged
80 and over

DNA Repeat Expansion
pathology [Motor Cortex]
Motor Cortex
Frontotemporal lobar degeneration
metabolism [Cerebellum]
Middle Aged
3. Good health
Frontal Lobe
metabolism [Motor Neuron Disease]
genetics [Amyotrophic Lateral Sclerosis]
metabolism [Frontal Lobe]
medicine.anatomical_structure
Frontotemporal Dementia
metabolism [Frontotemporal Dementia]
complications [Amyotrophic Lateral Sclerosis]
Female
genetics [Motor Neuron Disease]
Frontotemporal dementia
metabolism [Motor Cortex]
medicine.medical_specialty
complications [Cognition Disorders]
Heterozygote
pathology [Motor Neuron Disease]
Neuropathological diagnosis
Clinical Sciences
Clinical Neurology
Chromosome 9
and over
metabolism [RNA
Messenger]

Pathology and Forensic Medicine
Cellular and Molecular Neuroscience
metabolism [Cognition Disorders]
medicine
Humans
ddc:610
RNA
Messenger

Motor Neuron Disease
pathology [Amyotrophic Lateral Sclerosis]
Aged
c9RAN proteins
Original Paper
Neurology & Neurosurgery
C9orf72 Protein
business.industry
C9ORF72 repeat expansion
metabolism [Amyotrophic Lateral Sclerosis]
Amyotrophic Lateral Sclerosis
Neurosciences
Proteins
Repeat-associated non-ATG translation
medicine.disease
genetics [Proteins]
pathology [Hippocampus]
Protein Biosynthesis
pathology [Frontotemporal Dementia]
RNA
pathology [Cognition Disorders]
Neurology (clinical)
Human medicine
C9orf72 protein
human

Trinucleotide repeat expansion
business
Cognition Disorders
Zdroj: Acta neuropathologica 130(4), 559-573 (2015). doi:10.1007/s00401-015-1474-4
Acta neuropathologica, vol 130, iss 4
Acta neuropathologica
Acta Neuropathologica
ISSN: 0001-6322
Popis: Clinical and neuropathological characteristics associated with G4C2 repeat expansions in chromosome 9 open reading frame 72 (C9ORF72), the most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia, are highly variable. To gain insight on the molecular basis for the heterogeneity among C9ORF72 mutation carriers, we evaluated associations between features of disease and levels of two abundantly expressed “c9RAN proteins” produced by repeat-associated non-ATG (RAN) translation of the expanded repeat. For these studies, we took a departure from traditional immunohistochemical approaches and instead employed immunoassays to quantitatively measure poly(GP) and poly(GA) levels in cerebellum, frontal cortex, motor cortex, and/or hippocampus from 55 C9ORF72 mutation carriers [12 patients with ALS, 24 with frontotemporal lobar degeneration (FTLD) and 19 with FTLD with motor neuron disease (FTLD-MND)]. We additionally investigated associations between levels of poly(GP) or poly(GA) and cognitive impairment in 15 C9ORF72 ALS patients for whom neuropsychological data were available. Among the neuroanatomical regions investigated, poly(GP) levels were highest in the cerebellum. In this same region, associations between poly(GP) and both neuropathological and clinical features were detected. Specifically, cerebellar poly(GP) levels were significantly lower in patients with ALS compared to patients with FTLD or FTLD-MND. Furthermore, cerebellar poly(GP) associated with cognitive score in our cohort of 15 patients. In the cerebellum, poly(GA) levels similarly trended lower in the ALS subgroup compared to FTLD or FTLD-MND subgroups, but no association between cerebellar poly(GA) and cognitive score was detected. Both cerebellar poly(GP) and poly(GA) associated with C9ORF72 variant 3 mRNA expression, but not variant 1 expression, repeat size, disease onset, or survival after onset. Overall, these data indicate that cerebellar abnormalities, as evidenced by poly(GP) accumulation, associate with neuropathological and clinical phenotypes, in particular cognitive impairment, of C9ORF72 mutation carriers. Electronic supplementary material The online version of this article (doi:10.1007/s00401-015-1474-4) contains supplementary material, which is available to authorized users.
Databáze: OpenAIRE